Research suggests that intranasal nanosuspensions offer a promising way to formulate and deliver drugs that are poorly soluble in water to patients with chronic conditions.
Anirudh Gautam
Advertisement
Anirudh Gautam is senior director of R&D, Dr. Reddy’s Switzerland.
Articles by Anirudh Gautam
Advertisement
Latest Updated Articles
Assessment of Nanosuspension Formulation for Intranasal AdministrationSeptember 2nd 2020
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance
2
Leveraging an Innovative Mid-Scale Manufacturing Solution to Meet Diverse Needs
3
Faster Doesn’t Mean Easier: Development Impacts of a New Biosimilar Regulatory Landscape
4
A Pharma Manufacturing Blueprint from Delaware’s Innovation Vision
5